Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

View ORCID ProfileElisa Kortela, View ORCID ProfileVesa Kirjavainen, Maarit J. Ahava, Suvi T. Jokiranta, Anna But, View ORCID ProfileAnna Lindahl, View ORCID ProfileAnu E. Jääskeläinen, View ORCID ProfileAnnemarjut J. Jääskeläinen, View ORCID ProfileAsko Järvinen, Pia Jokela, Hannimari Kallio-Kokko, Raisa Loginov, Laura Mannonen, View ORCID ProfileEeva Ruotsalainen, Tarja Sironen, Olli Vapalahti, View ORCID ProfileMaija Lappalainen, View ORCID ProfileHanna-Riikka Kreivi, Hanna Jarva, View ORCID ProfileSatu Kurkela, View ORCID ProfileEliisa Kekäläinen
doi: https://doi.org/10.1101/2020.11.01.20223107
Elisa Kortela
1Division of Infectious diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elisa Kortela
Vesa Kirjavainen
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vesa Kirjavainen
Maarit J. Ahava
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suvi T. Jokiranta
3Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna But
4Biostatistics consulting, Department of Public Health, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Lindahl
5Department of Respiratory Medicine, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Lindahl
Anu E. Jääskeläinen
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anu E. Jääskeläinen
Annemarjut J. Jääskeläinen
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annemarjut J. Jääskeläinen
Asko Järvinen
1Division of Infectious diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Asko Järvinen
Pia Jokela
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannimari Kallio-Kokko
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raisa Loginov
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Mannonen
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eeva Ruotsalainen
1Division of Infectious diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eeva Ruotsalainen
Tarja Sironen
6Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
7Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olli Vapalahti
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
6Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
7Department of Veterinary Biosciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maija Lappalainen
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maija Lappalainen
Hanna-Riikka Kreivi
5Department of Respiratory Medicine, Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hanna-Riikka Kreivi
Hanna Jarva
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
3Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satu Kurkela
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satu Kurkela
  • For correspondence: satu.kurkela@hus.fi
Eliisa Kekäläinen
2HUSLAB Clinical Microbiology, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Finland
3Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eliisa Kekäläinen
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Importance Understanding the false negative rates of SARS-CoV-2 RT-PCR testing is pivotal for the management of the COVID-19 pandemic and it has practical implications for patient management in healthcare facilities.

Objective To determine the real-life clinical sensitivity of SARS-CoV-2 RT-PCR testing.

Design A retrospective study on case series from 4 March – 15 April 2020.

Setting A population-based study conducted in primary and tertiary care in the Helsinki Capital Region, Finland.

Participants Adults who were clinically suspected of SARS-CoV-2 infection and underwent SARS-CoV-2 RT-PCR testing, and who had sufficient data for grading of clinical suspicion of COVID-19 in their medical records were eligible. All 1,194 inpatients admitted to COVID-19 cohort wards during the study period were included. The outpatient cohort of 1,814 individuals was sampled from epidemiological line lists by systematic quasi-random sampling. Altogether 83 eligible outpatients (4.6%) and 3 inpatients (0.3%) were excluded due to insufficient data for grading of clinical suspicion.

Exposures High clinical suspicion for COVID-19 was used as the reference standard for the RT-PCR test. Patients were considered to have high clinical suspicion of COVID-19 if the physician in charge recorded the suspicion on clinical grounds, or the patient fulfilled specifically defined clinical and exposure criteria.

Main measures Sensitivity of SARS-CoV-2 RT-PCR by using manually curated clinical characteristics as the gold standard.

Results The study population included 1,814 outpatients (mean [SD] age, 45.4 [17.2] years; 69.1% women) and 1,194 inpatients (mean [SD] age, 63.2 [18.3] years; 45.2% women). The sensitivity (95% CI) for laboratory confirmed cases, i.e. repeatedly tested patients were as follows: 85.7% (81.5–89.1%) inpatients; 95.5% (92.2–97.5%) outpatients, 89.9% (88.2–92.1%) all. When also patients that were graded as high suspicion but never tested positive were included in the denominator, the following sensitivity values (95% CI) were observed: 67.5% (62.9–71.9%) inpatients; 34.9% (31.4–38.5%) outpatients; 47.3% (44.4–50.3%) all.

Conclusions and relevance The clinical sensitivity of SARS-CoV-2 RT-PCR testing was only moderate at best. The relatively high false negative rates of SARS-CoV-2 RT-PCR testing need to be accounted for in clinical decision making, epidemiological interpretations and when using RT-PCR as a reference for other tests.

Question What is the clinical sensitivity of SARS-CoV-2 RT-PCR test?

Findings In this population-based retrospective study on medical records of 1,814 outpatients and 1,194 inpatients, the clinical sensitivity of SARS-CoV-2 RT-PCR was 47.3–89.9%.

Meaning The false negative rates of SARS-CoV-2 RT-PCR testing need to be accounted for in clinical decision making, epidemiological interpretations and when using RT-PCR as a reference for other tests.

Competing Interest Statement

Dr. Kortela reports non-financial support from MSD, outside the submitted work. Prof. Jarvinen reports lecture honoraria from Astellas, OrionPharma, Pfizer, MSD, Sanofi and UnimedicPharma and consultation fee from CSL Behring outside the submitted manuscript. Dr. Kekalainen reports a lecture honorarium from MSD. Other authors have declared no competing interest.

Funding Statement

This work was supported by Academy of Finland (Kekalainen, grant no 308913) and Doctoral Programme in Biomedicine, Faculty of Medicine, University of Helsinki (Jokiranta).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the local review board (HUS/157/2020-29).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Researchers may contact study principal investigators to request access to data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
Elisa Kortela, Vesa Kirjavainen, Maarit J. Ahava, Suvi T. Jokiranta, Anna But, Anna Lindahl, Anu E. Jääskeläinen, Annemarjut J. Jääskeläinen, Asko Järvinen, Pia Jokela, Hannimari Kallio-Kokko, Raisa Loginov, Laura Mannonen, Eeva Ruotsalainen, Tarja Sironen, Olli Vapalahti, Maija Lappalainen, Hanna-Riikka Kreivi, Hanna Jarva, Satu Kurkela, Eliisa Kekäläinen
medRxiv 2020.11.01.20223107; doi: https://doi.org/10.1101/2020.11.01.20223107
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients
Elisa Kortela, Vesa Kirjavainen, Maarit J. Ahava, Suvi T. Jokiranta, Anna But, Anna Lindahl, Anu E. Jääskeläinen, Annemarjut J. Jääskeläinen, Asko Järvinen, Pia Jokela, Hannimari Kallio-Kokko, Raisa Loginov, Laura Mannonen, Eeva Ruotsalainen, Tarja Sironen, Olli Vapalahti, Maija Lappalainen, Hanna-Riikka Kreivi, Hanna Jarva, Satu Kurkela, Eliisa Kekäläinen
medRxiv 2020.11.01.20223107; doi: https://doi.org/10.1101/2020.11.01.20223107

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (860)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (250)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8566)
  • Forensic Medicine (4)
  • Gastroenterology (385)
  • Genetic and Genomic Medicine (1755)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1245)
  • Health Policy (622)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (376)
  • Infectious Diseases (except HIV/AIDS) (10306)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1679)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (451)
  • Oncology (929)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (254)
  • Primary Care Research (208)
  • Psychiatry and Clinical Psychology (1772)
  • Public and Global Health (3845)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (521)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)